PARKINSON'S DISEASE - 12 MARIJUANA RESEARCH PAPERS 2000 TO 2017
08/02/2017
Parkinson's disease enquiries ranks third in unique views (symptoms and conditions).
There is a lot of compelling research into the efficacy of cannabis based medicines in Parkinson's Disease. We're still battling the policy of disinformation by the Federal Government, despite the hope that the Trump Administration promised to lighten up on their funding of negative studies, research funded only with the intent to show something was wrong with cannabis based medicines, and nothing right. Under this scheme, the probability of a Federally funded research reporting something positive about marijuana is indeed slim, to none.
With that said, we present fourteen research groups, medical doctors and Ph.D.'s from acclaimed institutions that are not intimidated by peer pressure.
1 "Cannabis ranked among the most effective Complimentary and Alternate Therapies. Conclusions. Overall, our cross-sectional study was notable for a high rate of Complimentary and Alternate Therapies. utilization amongst Parkinsons patients and high rates of self-reported efficacy across most Complimentary and Alternate Therapies. modalities. Cannabis was rarely used in our population but users reported high efficacy, mainly for nonmotor symptoms."
2 An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit.. - 2004 Movement Disorder Society
3 "There were significant improvement of sleep and pain scores. No significant adverse effects of the drug were observed. The study suggests that cannabis might have a place in the therapeutic armamentarium of PD. Larger, controlled studies are needed to verify the results."
5 "Our findings point to a possible effect of CBD in improving quality of life measures in PD patients with no psychiatric comorbidities; however, studies with larger samples and specific objectives are required before definitive conclusions can be drawn."
6 "Cannabidiol (CBD) did not worsen the motor function while decreasing the total scores of the Unified Parkinson’s Disease Rating Scale. No adverse effects were observed during at any point in the treatment. These preliminary data suggest that Cannabidiol could bell be effective, safe and well tolerated in the treatment in Parkinsons Disease."
7 Israel researchers at Tel Aviv University Medical Center demonstrated how 22 patients with Parkinson’s disease had symptoms alleviated by oral administration of medical marijuana. Rsearchers reported significant improvements in PD symptoms; . reduced tremors, lesseneing of rigidity and dyskinesia. Additionally, the researchers also observed that patients were able to sleep better and and showed improvemed pain scores. Interestingly, the study did not report any significant adverse effects resulting from the use of medical marijuana in these PD studies.
8 In a recent NIH study, results suggested the effectiveness of cannabis. According to the National Biotechnology Information arm of the NIH, twenty two patients had favorable results in separate clinical trials in 2011 and 2012. Users' total scores on the Motor Examination portion of the Unified Parkinson Disease Rating Scale improved significantly from the mean of 33 at baseline to 23 after cannabis consumption (40% improvement. Analysis of specific motor symptoms showed significant lessening of tremors- as well as improved sleep and pain scores after smoking cannabis for 30 minutes. Thus it is suggested that cannabis could have a therapeutic effect in Parkinson's disease, but a large-scale study needs to be conducted to further measure the success of the treatment in PD.
9 Daily treatment with cannabidiol (CBD) led toimproved well-being and quality of life scores within a small group of Parkinson’s disease sufferers.This study was conducted by researchers from Brazil, Cannabidiol (CBD) was administered orally with gelatin capsules over a six-week period. The study number was 21 patients, who were given either 75mg per day, 300mg per day and placebo.
12 Medical cannabis is increasingly used as a treatment or adjunct treatment with different levels of efficacy in several neurological disorders or related symptoms (such as multiple sclerosis, autism, Parkinson and Alzheimer disease, Tourette's syndrome,
MMJDOCTORONLINE: In California, to purchase marijuana - recreational or medical, you must have a medical marijuana ID. Come Jan 1, 2016, any adult may buy marijuana, but recreational users will have to pay about 35% more, or about $80 per ounce than Cannabis ID card holders.
Fortunately the Calfiornia Medical Board has approved the use of telemedicine, which is basically online medical services, which has made it really easy for patients to apply for a doctor's medical recommendation, which allows for the purchase of cannabis, concentrates and other forms at dispensaries, cannabis clubs, cooperatives, compassion clubs and online delivery services.
Our process is completed 100% online and takes only a few minutes of your time. A doctor is standing by to process your request, normally within an hour or so, depending on volumes. Patient's are not asked to pay unless they are approved.
